Transfection Reagents & Equipment Market Growth is Driven by Advances in Gene Therapy, Rising Genetic Disease Research and High-Efficiency Delivery Methods.Austin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- ...
IMNN-001 program is currently advancing its OVATION 3 pivotal Phase 3 trial per planLAWRENCEVILLE, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ...
The host cell system is a critical determinant of recombinant protein quality and yield, with direct influence on protein ...
Lonza has added new solutions to its TheraPEAK® portfolio, introducing AmpliCell® Cytokines and 293-GT® Medium to support ...
Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...
The FEOX biosensor offers real-time insights into intracellular iron dynamics, enhancing understanding of stem cell ...
CD19 chimeric antigen receptor (CAR) T-cell therapy showed potential in treating patients with refractory systemic lupus erythematosus (SLE), with B-cell depletion and disease activity reduction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback